Cancer Immunology and Oncolytic Virology: Technologies and Global Markets

1
Cancer Immunology and Oncolytic Virology
Technologies and Global Markets
One-Stop Shop for Business Information
2
Summary
The global cancer immunotherapies market reached
30.8 billion in 2012. This market is expected to
grow to nearly 34.3 billion in 2013 and 67.9
billion in 2018 with a compound annual growth
rate (CAGR) of 14.7 over the five-year period,
2013 to 2018. This report provides -An overview
of the global market for cancer
immunotherapies. -Analyses of global market
trends, with data from 2012, estimates for 2013,
and projections of CAGRs through 2018. -Analyses
of factors influencing market demand such as
clinical guidelines, demographic changes, and
market saturation. -Technological discussion
including the current state, newly issued
patents, and pending applications. -Profiles of
leading companies in the industry.
3
Study goals and objectives
This report, PHM129A Cancer Immunology and
Oncolytic Virology Technologies and Global
Markets provides an overview of the current and
potential global market for cancer immunotherapy
and virology. The report provides comprehensive
information on a number of the most common
cancers, highlighting global incidence and
prevalence. It identifies the need for more
effective drugs for treatment of these diseases.
The key objective is to present a comprehensive
analysis of the current state of cancer
immunotherapy and where this field is going. A
second objective is to examine the current state
of oncolytic virology and where this nascent
field appears to be heading. Important trends in
each field, clinical trials and results, new
developments and sales forecasts for cancer
immunotherapy from 2011 through 2018 are provided
in this report. In addition, sales forecasts are
presented for oncolytic virology covering the
years 2011 through 2023.
4
Reasons
This study was conducted to provide detailed
information regarding the new area of
immunology-based treatment options for cancer.
There is an increasing need for new and
innovative drugs. This young industry is
experiencing tremendous growth. Many diseases
discussed in this report are global issues, and a
need exists for newer, more efficacious treatment
strategies. This study looks at the latest types
of treatment strategies based on immunology, as
well as the new field of oncolytic virotherapy, a
field still in its infancy showing immense
promise for the clinical management of
cancer. This BCC Research market research report
will increase the readers awareness of current
and emerging drugs and technologies for many
cancers.
5
Scope
The scope of this study entails the current
immunology therapeutics markets for several of
the most common cancers. The sectors covered are
colony stimulating factors (CSFs), interferon
alfa and gamma products, interleukin products and
therapeutic monoclonal antibodies, including
antibody conjugates, cancer vaccines and other
cancer treatment immunology products. Vaccines
against HPV and hepatitis B are included while
such vaccines act only indirectly against cancer,
they do serve to protect against the disease.
Also covered is oncolytic virology, so new that
its market tables have been presented separately
from the immunotherapy tables. The report also
includes discussion of the regulatory
environment, current and developing technologies,
cancer incidence, market projections and market
share, along with latest trends and clinical
trials.
6
INFORMATION SOURCES A number of companies within
the industry were surveyed to obtain data for
this study. Included were manufacturers and end
users of products, such as the pharmaceutical and
biotechnical industries and research institutes.
Data were gathered from various industry sources.
BCC Research spoke with officials within the
industry and consulted newsletters, company
literature, product literature and a host of
technical articles, journals, indexes and
abstracts. Exhaustive investigations of databases
by key terminology were completed. In addition,
data were compiled from current financial, trade
and government sources.
7
Table Of Content

1. INTRODUCTION
2. SUMMARY
3. OVERVIEW
4. OVERVIEW OF CANCER IMMUNOTHERAPY
5. ONCOLYTIC VIROTHERAPY
6. MAJOR MARKETS
7. TECHNOLOGY
8. COMPANY PROFILES
9. SELECTED COMPANY PROFILES

8
Related Reports

• Non-Small Cell Lung Cancer Global Clinical Trials
  Review, H1, 2014
• Metastatic Breast Cancer Global Clinical Trials
  Review, H1, 2014
• Neuroendocrine Cancer Global Clinical Trials
  Review, H1, 2014
• Nasopharyngeal Cancer Global Clinical Trials
  Review, H1, 2014
• Hormone-Sensitive Prostate Cancer Global Clinical
  Trials Review, H1, 2014
• OpportunityAnalyzer Pancreatic Cancer -
  Opportunity Analysis and Forecasts to 2017

9
Custom Research

• Incase the reports dont match your
  requirement then we can do a Custom Research for
  you. Our multifarious capabilities, cross-sector
  expertise and detailed knowledge of various
  markets, put us at a unique position to take up
  Custom Research demands of yours. We provide the
  specifications of the custom research job to a
  dedicated team comprising of researchers,
  analysts and industry experts, who have close
  experience and understanding of global markets,
  competitive landscapes, various business models,
  market shares, drivers, restraints and benchmarks.

10

• To know more
• Cancer Immunology and Oncolytic Virology
  Technologies and Global Markets

Contact Us-Call India 91-22-27810772/73 Call
USA/Canada (Toll Free) 1-866-279-8368 Email id
info_at_bharatbook.com